| Taryn D Linton, | |
|
Berlin Health & Rehab, 98 Hospitality Dr., Barre, VT 05641 | |
| (802) 229-0308 | |
| Not Available |
| Full Name | Taryn D Linton |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | Berlin Health & Rehab, Barre, Vermont |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104545904 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 025435 (New York) | Secondary |
| 225X00000X | Occupational Therapist | 072.0134149 (Vermont) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Taryn D Linton, Berlin Health & Rehab, 98 Hospitality Dr., Barre, VT 05641 Ph: () - | Taryn D Linton, Berlin Health & Rehab, 98 Hospitality Dr., Barre, VT 05641 Ph: (802) 229-0308 |
News Archive
Palatin Technologies, Inc. today reported positive top-line results, including the successful achievement of statistical significance for the primary endpoint and key secondary endpoints in its Phase 2B clinical trial evaluating the efficacy and safety of bremelanotide for the treatment of female sexual dysfunction (FSD).
Seaside Therapeutics LLC today announced the issuance of U.S. patent 7,648,993 B2 (‘993 patent), which covers methods of treating autism with group 1 antagonists of the metabotropic glutamate receptor (mGluR) pathway. An earlier related patent, U.S. patent 6,890,931 B2 (‘931 patent), was issued in 2005 and covers methods of treating Fragile X Syndrome, the most common known cause of autism, with group 1 antagonists of the mGluR pathway.
The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, which recently expanded its focus to include evaluating outpatient treatment for COVID-19, today announced that Teresa H. Evering, M.D., M.S., a co-lead investigator (with Eric S. Daar, M.D.) for BRII-196/BRII-198 in the ACTIV-2 study of Outpatient Monoclonal Antibodies and Other Therapies, will present data for the monoclonal antibody combination at the virtual IDWeek 2021 conference, taking place September 29 – October 3, 2021.
The healthcare industry in Europe is fragmented with several vendors controlling different niche segments. Early technology vendors that implemented legacy systems still have a hold on pockets of provider groups both in the primary, secondary and acute care segments, simply because the end users do not have the resources for expensive upgrades.
› Verified 6 days ago
Mrs. Wendy Crowe Watson, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 98 Hospitality Dr, Barre, VT 05641 Phone: 802-220-0308 | |
John J. Barry, O.T. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 654 Granger Rd, Barre, VT 05641 Phone: 615-778-4066 Fax: 615-778-4066 | |
Ms. Linda Beth Lewis Riddle, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 28 Daniel Dr, Barre, VT 05641 Phone: 802-479-6952 | |
Tammy Cote, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 98 Hospitality Drive, Barre, VT 05641 Phone: 802-229-0308 | |
Mr. Brian Labelle, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 98 Hospitality Dr, Barre, VT 05641 Phone: 802-229-0308 | |
Mr. Daniel E Rines, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 98 Hospitality Dr, Barre, VT 05641 Phone: 802-229-0308 |